sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Europe Biosimilars Market Scope And Analysis

  • Report Code : TIPRE00030025
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 205
Buy Now

Europe Biosimilars Market Analysis, Size, and Growth (2023-2030)

Buy Now

Europe Biosimilars Market Report Europe Biosimilars Market Size and Share Europe Biosimilars Market Scope and Analysis

Europe Biosimilars Market Report Scope

Report Attribute Details
Market size in 2022 US$ 10,344.86 Million
Market Size by 2030 US$ 115,125.91 Million
Global CAGR (2022 - 2030) 35.1%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By Disease Indication
  • Cancer
  • Diabetes
  • Autoimmune Disease
  • Other Disease Indication
By Route of Administration
  • Intravenous
  • Subcutaneous
By Drug Class
  • Granulocyte Colony-Stimulating Factor
  • Insulin
  • TNF Blockers and Monoclonal Antibodies
By Distribution Channel
  • Hospital Pharmacies
  • Compounding Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Regions and Countries Covered Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Market leaders and key company profiles
  • Amgen Inc
  • Celltrion Inc
  • Sanofi SA
  • Biocon Ltd
  • Samsung Bioepis Co Ltd
  • Elli Lilly and Co
  • Sandoz AG
  • Teva Pharmaceitical Industries Ltd
  • Pfizer Inc